272 related articles for article (PubMed ID: 27406638)
1. Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol.
Coutsoudis A; Daniels B; Moodley-Govender E; Ngomane N; Zako L; Spooner E; Kiepiela P; Reddy S; Kuhn L; Ramjee G
BMJ Open; 2016 Jul; 6(7):e010656. PubMed ID: 27406638
[TBL] [Abstract][Full Text] [Related]
2. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
[TBL] [Abstract][Full Text] [Related]
3. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
[TBL] [Abstract][Full Text] [Related]
4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
5. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
6. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
[TBL] [Abstract][Full Text] [Related]
8. Exclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South Africa.
Rollins NC; Ndirangu J; Bland RM; Coutsoudis A; Coovadia HM; Newell ML
PLoS One; 2013; 8(12):e81307. PubMed ID: 24312545
[TBL] [Abstract][Full Text] [Related]
9. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
Morden E; Technau KG; Giddy J; Maxwell N; Keiser O; Davies MA
PLoS One; 2016; 11(4):e0151762. PubMed ID: 27049853
[TBL] [Abstract][Full Text] [Related]
10. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
11. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
Nagot N; Kankasa C; Tumwine JK; Meda N; Hofmeyr GJ; Vallo R; Mwiya M; Kwagala M; Traore H; Sunday A; Singata M; Siuluta C; Some E; Rutagwera D; Neboua D; Ndeezi G; Jackson D; Maréchal V; Neveu D; Engebretsen IMS; Lombard C; Blanche S; Sommerfelt H; Rekacewicz C; Tylleskär T; Van de Perre P;
Lancet; 2016 Feb; 387(10018):566-573. PubMed ID: 26603917
[TBL] [Abstract][Full Text] [Related]
12. Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.
Aizire J; Fowler MG; Wang J; Shetty AK; Stranix-Chibanda L; Kamateeka M; Brown ER; Bolton SG; Musoke PM; Coovadia H
AIDS; 2012 Jan; 26(3):325-33. PubMed ID: 22112598
[TBL] [Abstract][Full Text] [Related]
13. Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana.
Powis KM; Souda S; Lockman S; Ajibola G; Bennett K; Leidner J; Hughes MD; Moyo S; van Widenfelt E; Jibril HB; Makhema J; Essex M; Shapiro RL
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29119726
[TBL] [Abstract][Full Text] [Related]
14. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa.
Coutsoudis A; Pillay K; Spooner E; Coovadia HM; Pembrey L; Newell ML
S Afr Med J; 2005 May; 95(5):339-45. PubMed ID: 15931449
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection.
Humphreys EH; Smith NA; Azman H; McLeod D; Rutherford GW
Cochrane Database Syst Rev; 2010 Jun; (6):CD008563. PubMed ID: 20556793
[TBL] [Abstract][Full Text] [Related]
16. Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol.
Shivakoti R; Slogrove AL; Laughton B; Shafiq M; Schoeman E; Glashoff RH; Leu CS; Wang S; Bode L; Aldrovandi G; Kuhn L
BMJ Open; 2022 Dec; 12(12):e069116. PubMed ID: 36585139
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of interventions to improve uptake and retention of HIV-infected pregnant and breastfeeding women and their infants in prevention of mother-to-child transmission care programs in low- and middle-income countries: protocol for a systematic review and meta-analysis.
Puchalski Ritchie LM; van Lettow M; Hosseinipour MC; Rosenberg NE; Phiri S; Landes M; Cataldo F; Straus SE;
Syst Rev; 2015 Nov; 4():144. PubMed ID: 26525141
[TBL] [Abstract][Full Text] [Related]
18. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda.
Homsy J; Moore D; Barasa A; Were W; Likicho C; Waiswa B; Downing R; Malamba S; Tappero J; Mermin J
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):28-35. PubMed ID: 19797972
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.
Moodley D; Reddy L; Mahungo W; Masha R
PLoS One; 2013; 8(5):e63273. PubMed ID: 23667599
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial.
Sandison TG; Homsy J; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Kalamya J; Vora N; Kublin J; Kamya MR; Dorsey G; Tappero JW
BMJ; 2011 Mar; 342():d1617. PubMed ID: 21454456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
